32.64
-0.07 (-0.21%)
| Penutupan Terdahulu | 32.71 |
| Buka | 32.80 |
| Jumlah Dagangan | 25,547 |
| Purata Dagangan (3B) | 30,532 |
| Modal Pasaran | 285,311,456 |
| Harga / Jualan (P/S) | 3.63 |
| Harga / Buku (P/B) | 7.36 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 24 Mar 2025 - 28 Mar 2025 |
| Margin Keuntungan | -10.71% |
| Margin Operasi (TTM) | -6.22% |
| EPS Cair (TTM) | -0.990 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 35.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 80.91% |
| Nisbah Semasa (MRQ) | 2.22 |
| Aliran Tunai Operasi (OCF TTM) | -1.80 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.72 M |
| Pulangan Atas Aset (ROA TTM) | -5.08% |
| Pulangan Atas Ekuiti (ROE TTM) | -20.28% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | Sanara MedTech Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 2.50 |
|
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 66.56% |
| % Dimiliki oleh Institusi | 9.40% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| World Investment Advisors, Llc | 30 Sep 2024 | 21,112 |
| Salem Investment Counselors Inc | 31 Dec 2024 | 11,215 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 50.00 (HC Wainwright & Co., 53.19%) | Beli |
| Median | 47.00 (44.00%) | |
| Rendah | 44.00 (Cantor Fitzgerald, 34.80%) | Beli |
| Purata | 47.00 (44.00%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 38.12 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Cantor Fitzgerald | 23 Jan 2025 | 44.00 (34.80%) | Beli | 38.12 |
| 22 Jan 2025 | 44.00 (34.80%) | Beli | 37.72 | |
| HC Wainwright & Co. | 23 Jan 2025 | 50.00 (53.19%) | Beli | 38.12 |
| 23 Dec 2024 | 50.00 (53.19%) | Beli | 34.11 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 24 Jan 2025 | Pengumuman | Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc. |
| 21 Jan 2025 | Pengumuman | Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd |
| 21 Jan 2025 | Pengumuman | Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments |
| 21 Jan 2025 | Pengumuman | Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024 |
| 25 Nov 2024 | Pengumuman | Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th |
| 12 Nov 2024 | Pengumuman | Sanara MedTech Inc. Reports Third Quarter 2024 Results |
| 31 Oct 2024 | Pengumuman | Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |